Brainsway Stock Buy Hold or Sell Recommendation
| BRSYF Stock | USD 3.15 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding BrainsWay is 'Cautious Hold'. Macroaxis provides BrainsWay buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BRSYF positions.
Check out BrainsWay Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in BrainsWay Pink Sheet please use our How to Invest in BrainsWay guide. Note, we conduct extensive research on individual companies such as BrainsWay and provide practical buy, sell, or hold advice based on investors' constraints. BrainsWay. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
BrainsWay |
Execute BrainsWay Buy or Sell Advice
The BrainsWay recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BrainsWay. Macroaxis does not own or have any residual interests in BrainsWay or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BrainsWay's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
BrainsWay Trading Alerts and Improvement Suggestions
| BrainsWay is way too risky over 90 days horizon | |
| BrainsWay appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 29.66 M. Net Loss for the year was (6.46 M) with profit before overhead, payroll, taxes, and interest of 24.35 M. | |
| About 20.0% of the company shares are held by company insiders |
BrainsWay Returns Distribution Density
The distribution of BrainsWay's historical returns is an attempt to chart the uncertainty of BrainsWay's future price movements. The chart of the probability distribution of BrainsWay daily returns describes the distribution of returns around its average expected value. We use BrainsWay price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BrainsWay returns is essential to provide solid investment advice for BrainsWay.
| Mean Return | 0.76 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 6.15 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BrainsWay historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BrainsWay Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BrainsWay or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BrainsWay's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BrainsWay pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.75 | |
β | Beta against Dow Jones | -0.05 | |
σ | Overall volatility | 6.20 | |
Ir | Information ratio | 0.10 |
BrainsWay Volatility Alert
BrainsWay is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BrainsWay's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BrainsWay's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.BrainsWay Fundamentals Vs Peers
Comparing BrainsWay's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BrainsWay's direct or indirect competition across all of the common fundamentals between BrainsWay and the related equities. This way, we can detect undervalued stocks with similar characteristics as BrainsWay or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of BrainsWay's fundamental indicators could also be used in its relative valuation, which is a method of valuing BrainsWay by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BrainsWay to competition |
| Fundamentals | BrainsWay | Peer Average |
| Return On Equity | -0.2 | -0.31 |
| Return On Asset | -0.0751 | -0.14 |
| Profit Margin | (0.37) % | (1.27) % |
| Operating Margin | (0.29) % | (5.51) % |
| Current Valuation | (24.98 M) | 16.62 B |
| Shares Outstanding | 33.08 M | 571.82 M |
| Shares Owned By Insiders | 19.83 % | 10.09 % |
| Shares Owned By Institutions | 1.11 % | 39.21 % |
| Price To Earning | (23.91) X | 28.72 X |
| Price To Book | 0.61 X | 9.51 X |
| Price To Sales | 1.11 X | 11.42 X |
| Revenue | 29.66 M | 9.43 B |
| Gross Profit | 24.35 M | 27.38 B |
| EBITDA | (3.31 M) | 3.9 B |
| Net Income | (6.46 M) | 570.98 M |
| Cash And Equivalents | 52.45 M | 2.7 B |
| Cash Per Share | 1.50 X | 5.01 X |
| Total Debt | 754 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 7.71 X | 2.16 X |
| Book Value Per Share | 1.46 X | 1.93 K |
| Cash Flow From Operations | 884 K | 971.22 M |
| Earnings Per Share | (0.22) X | 3.12 X |
| Target Price | 10.75 | |
| Number Of Employees | 118 | 18.84 K |
| Beta | 0.2 | -0.15 |
| Market Capitalization | 35.72 M | 19.03 B |
| Total Asset | 75.73 M | 29.47 B |
| Retained Earnings | (47 M) | 9.33 B |
| Working Capital | 10 M | 1.48 B |
| Current Asset | 14 M | 9.34 B |
| Current Liabilities | 4 M | 7.9 B |
| Z Score | 28.2 | 8.72 |
BrainsWay Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BrainsWay . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About BrainsWay Buy or Sell Advice
When is the right time to buy or sell BrainsWay? Buying financial instruments such as BrainsWay Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having BrainsWay in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Buywrite ETFs Thematic Idea Now
Buywrite ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Buywrite ETFs theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Buywrite ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in BrainsWay Pink Sheet
When determining whether BrainsWay offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BrainsWay's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock:Check out BrainsWay Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in BrainsWay Pink Sheet please use our How to Invest in BrainsWay guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.